Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Tepezza
Pharma
Improved access helps Amgen's Tepezza to a sales increase
In the second quarter, Amgen's Tepezza emerged from its stagnation ,generating $479 million in sales for an increase of 8% YOY and 13% sequentially.
Kevin Dunleavy
Aug 7, 2024 8:35am
Amid buzz for Amgen's obesity drug, company sees revenue boost
May 3, 2024 9:05am
Amgen reports 3rd straight sequential sales increase for Tepezza
Feb 7, 2024 10:03am
Amgen lays out plan to boost sales of newly acquired Tepezza
Oct 31, 2023 11:29am
Amgen settles with FTC over its $28B Horizon buyout
Sep 1, 2023 10:03am
Amgen fights FTC's request for injunction against Horizon buyout
Aug 24, 2023 11:12am
